Skip to main content

Clinical Trials

Trials

A PHASE 3 SINGLE CENTER STUDY OF ISLET TRANSPLANTATION IN NON-UREMIC DIABETIC PATIENTS

Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, specifically using Campath as induction, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episodes.
Borja-Cacho, DanielBorja-Cacho, Daniel
NCT01897688 STU00059469
More Info
Copy

Neural Systems for the Dynamic Use of Memory

The Laboratory for Human Neuroscience at the Northwestern University Feinberg School of Medicine is seeking participants for research studies on how the brain develops across the lifespan. We are currently enrolling individuals 18-34 years of age in our research studies. Depending on your eligibility, you could take part in …
The Laboratory for Human Neuroscience at the Northwestern University Feinberg School of Medicine is seeking participants for research studies on how the brain develops across the lifespan. We are currently enrolling individuals 18-34 years of age in our research studies. Depending on your eligibility, you could take part in studies involving cognitive testing or studies involving noninvasive recording of brain function (using EEG, TMS, and MRI). Please contact us if you are interested in participating and we can determine your eligibility and provide additional details. All studies take place in downtown Chicago on the Northwestern University campus. Individuals will receive monetary compensation for participating, ranging from $10-$40 per hour depending on the experiment. Please contact fill out our participant survey if you are interested at https://redcap.nubic.northwestern.edu/redcap/surveys/?s=w7RfNPbxwJ or contact us at lhn@northwestern.edu or 312-503-5613.
Voss, Joel LVoss, Joel L
STU00060723
More Info
Copy

Noninvasive Manipulation of Hippocampal-Cortical Brain Networks and Memory

The Laboratory for Human Neuroscience at the Northwestern University Feinberg School of Medicine is seeking participants for research studies on how the brain develops across the lifespan. We are currently enrolling individuals 18-34 years of age in our research studies. Depending on your eligibility, you could take part in …
The Laboratory for Human Neuroscience at the Northwestern University Feinberg School of Medicine is seeking participants for research studies on how the brain develops across the lifespan. We are currently enrolling individuals 18-34 years of age in our research studies. Depending on your eligibility, you could take part in studies involving cognitive testing or studies involving noninvasive recording of brain function (using EEG, TMS, and MRI). Please contact us if you are interested in participating and we can determine your eligibility and provide additional details. All studies take place in downtown Chicago on the Northwestern University campus. Individuals will receive monetary compensation for participating, ranging from $10-$40 per hour depending on the experiment. Please fill out our participant survey if you are interested at https://redcap.nubic.northwestern.edu/redcap/surveys/?s=w7RfNPbxwJ or contact us at lhn@northwestern.edu or 312-503-5613.
Voss, Joel LVoss, Joel L
STU00070522
More Info
Copy

OPT2MOVE

About the StudyOpt2Move is a 6-month smartphone-based study to help adolescent and young adult cancer survivors become more active.What’s involved? AssessmentsComplete before starting study and at 3 and 6 months: 45-min online surveyWear activity monitor 24/7 for 7 days You will be compensated for …

About the Study

Opt2Move is a 6-month smartphone-based study to help adolescent and young adult cancer survivors become more active.

What’s involved?

Assessments

Complete before starting study and at 3 and 6 months:

  • 45-min online survey
  • Wear activity monitor 24/7 for 7 days
  • You will be compensated for assessment completion

Physical Activity Program

All Participants

  • Receive Fitbit, Opt2Move app, exercise prescription, 15-min orientation call
  • Track physical activity with Fitbit and use Opt2Move app daily
  • Additionally, you may receive 0-4 additional Opt2Move features focused on mindfulness and/or social support.

How can I learn more?

For questions: Phone: 312-503-3465; Email: O2M@nm.org

To complete online screening: https://redcap.link/O2M

Who can participate?

  • Adults (18-39) diagnosed with cancer (except non-melanoma skin cancer) at age 18-39
  • 5 years or less since cancer diagnosis
  • 3 months or more since completed primary treatment (i.e., surgery, chemotherapy, and/or radiation); may still be undergoing endocrine or hormonal therapies
  • Fluent in spoken and written English
  • Own a smartphone that is either an iPhone (version 5 or greater) or an Android (version 5.0 or greater)
  • Have internet access
  • Have no absolute contraindications to exercise (e.g., acute myocardial infarction, severe orthopedic conditions, or metastatic disease) OR willing to obtain medical clearance from a primary care physician if necessary
  • Engage in less than 60 minutes total each week of moderate to vigorous intensity physical activities such as walking, biking, or swimming
  • Willing to find a Buddy (someone who knows about your cancer and participation in this study and who is willing to participate by supporting you during the 6-month study)
Phillips, Siobhan MPhillips, Siobhan M
NCT05375162 STU00210628
More Info
Copy

Follow MSS on